What we know, and what we still don't, about microplastics

Microplastics coverage tends to arrive in two flavors. One says the sky is falling. The other says nothing is proven, so nothing is worth doing. Neither is fair to the actual science.

The honest picture sits in between, and it is worth laying out plainly. Here is how we think about it: three things the research genuinely shows, and three things it does not yet.

What we know

1. Plastic particles reach human tissue.

This is the most stable finding in the field, and it comes from more than one instrument in more than one lab. Researchers using infrared imaging have identified plastic particles in the olfactory bulb of the human brain in more than half the people they examined ^[1]. A separate group found plastic fragments inside the artery plaques of patients undergoing surgery for carotid disease ^[2]. We unpacked that particular study, and what its headline number really means, in Plastic in your arteries: what those headlines really mean. Others have identified particles in placenta, testis, blood, and stool.

These findings do not all use the same technique, which matters. When independent methods keep pointing at the same qualitative answer, the answer is usually real.

2. Everyday exposure sources are identifiable.

Some routes are now well characterized. Heating food in plastic containers releases particles. So does boiling water in plastic kettles, drinking from single-use bottles, and eating from paper cups lined with plastic film. One 2024 study using a laser-based imaging technique counted roughly a quarter-million tiny plastic particles per liter of bottled water ^[3].

None of these numbers reflect a single scandalous product. They reflect a modern environment in which plastic touches nearly everything we eat, drink, and breathe.

3. In laboratory models, plastic particles do things.

In animal studies and cell studies, microplastics and nanoplastics have been shown to cross biological barriers, trigger inflammation, disrupt hormone signaling, and interfere with tissue development ^[4-5]. The effects are consistent enough across independent labs that most researchers now treat "microplastics are biologically inert" as a claim that has not survived contact with the evidence.

What we still don't know

1. How much is actually in a given person.

This is the honest, uncomfortable answer: the exact quantitative burden (such as how many micrograms of which polymer sit in which tissue) is not yet reliable. The technique behind most of the widely quoted numbers has a known problem. When blood samples are heated during analysis, natural fats in the blood break down into the same chemical fragments that plastic breaks into. That means the instrument cannot always tell the two apart ^[6]. When 84 qualified labs were handed identical reference samples and asked to measure them, their results disagreed with each other by factors of two to ten ^[7].

The particles are there. The precise number attached to any given headline is often shakier than the headline suggests. If you want a longer read on this, we walked through the measurement problem in detail in The challenge of measuring plastics in humans.

2. Whether measured exposure causes specific human disease.

Association is not the same as causation, and the human evidence today is mostly association. The carotid plaque study, for example, found that patients whose plaques contained plastic had well over four times the rate of heart attacks, strokes, and deaths over about three years compared to patients whose plaques did not ^[2]. That is a striking signal. It is not proof that the plastic caused the events. People with more plastic in their arteries may also differ in dozens of other ways.

The mechanistic case for harm is strong in animal and cell studies. The human outcome data are still early.

3. Which interventions actually lower risk in people.

Filtered water reduces particles in what you drink. Not heating food in plastic reduces migration into what you eat. These are reasonable steps and the logic behind them is solid. What has not been demonstrated is that any specific intervention (e.g., dietary, filtration, or supplement) measurably improves a human health outcome tied to microplastic exposure. That study has not been done yet, in part because the measurement problem above makes it hard to design.

Where Winnow fits, plainly

This is the part where a lot of companies overreach. We try not to.

Winnow is a probiotic that has been shown in laboratory testing to bind micro- and nanoplastics. That is a specific claim about a specific mechanism. It is not a claim that Winnow removes plastic already lodged in blood, brain, or organs. It is not a detox. It is not a treatment for any disease. Anyone selling a supplement as those things is ahead of the evidence.

What Winnow offers is steady support at the doorway — gut armor for a living threshold that the modern environment relentlessly tests.

The principle

The two most common mistakes in this conversation are opposite mistakes. One is treating every new microplastics headline as settled. The other is treating uncertainty as license to do nothing. Both dodge the actual work.

The actual work is patient. It is naming what the science shows, naming what it does not, and acting on the parts that are stable while the rest matures. It is what we try to do here, and it is what we try to build the product around.

If a claim is bigger than the evidence, we would rather not make it. If a claim is smaller than the evidence, we would rather not shrink it. Somewhere between those two disciplines is a company worth trusting. If you want a longer companion piece on how we read this literature, and where we let uncertainty stay uncertain, we wrote one: How we evaluate scientific evidence.